These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30755441)

  • 1. Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities.
    Robinson TJ; Freedman JA; Al Abo M; Deveaux AE; LaCroix B; Patierno BM; George DJ; Patierno SR
    Clin Cancer Res; 2019 May; 25(10):2963-2968. PubMed ID: 30755441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer.
    Jyotsana N; Heuser M
    Expert Opin Ther Targets; 2018 Feb; 22(2):107-121. PubMed ID: 29235382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential alternative RNA splicing and transcription events between tumors from African American and White patients in The Cancer Genome Atlas.
    Al Abo M; Hyslop T; Qin X; Owzar K; George DJ; Patierno SR; Freedman JA
    Genomics; 2021 May; 113(3):1234-1246. PubMed ID: 33705884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics.
    Bessa C; Matos P; Jordan P; Gonçalves V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other Cancers.
    Sahin I; George A; Seyhan AA
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
    Urbanski LM; Leclair N; Anczuków O
    Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomics and solid tumors: The next frontier in precision cancer medicine.
    Tsimberidou AM; Fountzilas E; Bleris L; Kurzrock R
    Semin Cancer Biol; 2022 Sep; 84():50-59. PubMed ID: 32950605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
    Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
    Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA splicing: a dual-edged sword for hepatocellular carcinoma.
    Kashyap A; Tripathi G; Tripathi A; Rao R; Kashyap M; Bhat A; Kumar D; Rajhans A; Kumar P; Chandrashekar DS; Mahmood R; Husain A; Zayed H; Bharti AC; Kashyap MK
    Med Oncol; 2022 Aug; 39(11):173. PubMed ID: 35972700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating proteomics into precision oncology.
    Wahjudi LW; Bernhardt S; Abnaof K; Horak P; Kreutzfeldt S; Heining C; Borgoni S; Becki C; Berg D; Richter D; Hutter B; Uhrig S; Pfütze K; Leichsenring J; Glimm H; Brors B; von Kalle C; Stenzinger A; Korf U; Fröhling S; Wiemann S
    Int J Cancer; 2021 Mar; 148(6):1438-1451. PubMed ID: 32949162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: The RNA revolution and cancer.
    Dlamini Z; Ladomery MR; Kahraman A
    Front Endocrinol (Lausanne); 2024; 15():1422599. PubMed ID: 38832352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy.
    Mehterov N; Kazakova M; Sbirkov Y; Vladimirov B; Belev N; Yaneva G; Todorova K; Hayrabedyan S; Sarafian V
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets.
    Adamia S; Haibe-Kains B; Pilarski PM; Bar-Natan M; Pevzner S; Avet-Loiseau H; Lode L; Verselis S; Fox EA; Burke J; Galinsky I; Dagogo-Jack I; Wadleigh M; Steensma DP; Motyckova G; Deangelo DJ; Quackenbush J; Stone R; Griffin JD
    Clin Cancer Res; 2014 Mar; 20(5):1135-45. PubMed ID: 24284058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
    Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
    Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles and mechanisms of alternative splicing in cancer - implications for care.
    Bonnal SC; López-Oreja I; Valcárcel J
    Nat Rev Clin Oncol; 2020 Aug; 17(8):457-474. PubMed ID: 32303702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing.
    Dvinge H; Guenthoer J; Porter PL; Bradley RK
    Genome Res; 2019 Oct; 29(10):1591-1604. PubMed ID: 31434678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities.
    Venkataramany AS; Schieffer KM; Lee K; Cottrell CE; Wang PY; Mardis ER; Cripe TP; Chandler DS
    Ann Oncol; 2022 Jun; 33(6):578-592. PubMed ID: 35339647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of splicing in cancer.
    Lee SC; Abdel-Wahab O
    Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics workflows for clinical applications in precision oncology.
    Jäger N
    Semin Cancer Biol; 2022 Sep; 84():103-112. PubMed ID: 33476720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine.
    Nasser S; Kurdolgu AA; Izatt T; Aldrich J; Russell ML; Christoforides A; Tembe W; Keifer JA; Corneveaux JJ; Byron SA; Forman KM; Zuccaro C; Keats JJ; Lorusso PM; Carpten JD; Trent JM; Craig DW
    Pac Symp Biocomput; 2015; ():56-67. PubMed ID: 25592568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.